Skip to main content
Clinical Trials/CTRI/2022/12/048178
CTRI/2022/12/048178
Not yet recruiting
未知

comparative evaluation of dexmedetomidine versus nalbuphine for control of post spinal shivering - DEX NA

dr d y patil vidyapeeth pimpri pune0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
dr d y patil vidyapeeth pimpri pune
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
dr d y patil vidyapeeth pimpri pune

Eligibility Criteria

Inclusion Criteria

  • ASA grade I \& II.
  • 2\. Age between 18 and 60 years of either sex.
  • 3\. Patients undergoing surgeries under spinal anaesthesia.
  • 4\. Haemodynamically stable patients with all routine investigations within normal limits.
  • 5\. Patients who are not on any cardiac related drugs
  • 5\. Availability of an informed consent.

Exclusion Criteria

  • . Patient refusal.
  • 2\. Patients with ASA physical status III or more.
  • 3\. Patients receiving sedative/ hypnotic agents.
  • 4\. Patients with uncontrolled hypertension, hyperthyroidism, hypothyroidism, psychiatric disorders, severe diabetes or autonomic neuropathy.
  • 5\. Patients with history of cardiac, respiratory, renal or hepatic diseases.
  • 6\. Patients with history of alcohol or drug abuse.
  • 7\. Patients who have a history of allergy to any of the test drugs.
  • 8\. Contraindications to spinal anaesthesia (coagulation disorder, infection at puncture site, raised intracranial tension, pre\-existing neurological deficit in lower extremities or any spine deformity).
  • 9\. Initial body temperature \>38°C or \<36°C

Outcomes

Primary Outcomes

Not specified

Similar Trials